These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2261474)

  • 1. Binding of the antitumor drug nogalamycin and its derivatives to DNA: structural comparison.
    Gao YG; Liaw YC; Robinson H; Wang AH
    Biochemistry; 1990 Nov; 29(45):10307-16. PubMed ID: 2261474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor drug nogalamycin binds DNA in both grooves simultaneously: molecular structure of nogalamycin-DNA complex.
    Liaw YC; Gao YG; Robinson H; van der Marel GA; van Boom JH; Wang AH
    Biochemistry; 1989 Dec; 28(26):9913-8. PubMed ID: 2620066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMR studies on the binding of antitumor drug nogalamycin to DNA hexamer d(CGTACG).
    Robinson H; Liaw YC; van der Marel GA; van Boom JH; Wang AH
    Nucleic Acids Res; 1990 Aug; 18(16):4851-8. PubMed ID: 2395646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antitumor drug nogalamycin forms two different intercalation complexes with d(GCGT).d(ACGC).
    van Houte LP; van Garderen CJ; Patel DJ
    Biochemistry; 1993 Feb; 32(6):1667-74. PubMed ID: 8431447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of the antitumor drug nogalamycin to bulged DNA structures.
    Caceres-Cortes J; Wang AH
    Biochemistry; 1996 Jan; 35(2):616-25. PubMed ID: 8555235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of the anthracycline antibiotic nogalamycin with the hexamer duplex d(5'-GACGTC)2. An NMR and molecular modelling study.
    Searle MS; Bicknell W
    Eur J Biochem; 1992 Apr; 205(1):45-58. PubMed ID: 1555603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of aglycone modifications on the binding of anthracycline drugs to DNA: the molecular structure of idarubicin and 4-O-demethyl-11-deoxydoxorubicin complexed to d(CGATCG).
    Gao YG; Wang AH
    Anticancer Drug Des; 1991 Jul; 6(3):137-49. PubMed ID: 1872945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A continuous transition from A-DNA to B-DNA in the 1:1 complex between nogalamycin and the hexamer dCCCGGG.
    Cruse WB; Saludjian P; Leroux Y; Léger G; Manouni DE; Prangé T
    J Biol Chem; 1996 Jun; 271(26):15558-67. PubMed ID: 8662899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of nogalamycin bound to a DNA hexamer.
    Williams LD; Egli M; Qi G; Bash P; van der Marel GA; van Boom JH; Rich A; Frederick CA
    Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2225-9. PubMed ID: 2315315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solution structure of the nogalamycin-DNA complex.
    Zhang XL; Patel DJ
    Biochemistry; 1990 Oct; 29(40):9451-66. PubMed ID: 2174261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-nogalamycin interactions.
    Egli M; Williams LD; Frederick CA; Rich A
    Biochemistry; 1991 Feb; 30(5):1364-72. PubMed ID: 1991116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA-nogalamycin interactions: the crystal structure of d(TGATCA) complexed with nogalamycin.
    Smith CK; Davies GJ; Dodson EJ; Moore MH
    Biochemistry; 1995 Jan; 34(2):415-25. PubMed ID: 7819233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between an anthracycline antibiotic and DNA: molecular structure of daunomycin complexed to d(CpGpTpApCpG) at 1.2-A resolution.
    Wang AH; Ughetto G; Quigley GJ; Rich A
    Biochemistry; 1987 Feb; 26(4):1152-63. PubMed ID: 3567161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR studies of the interaction of the antibiotic nogalamycin with the hexadeoxyribonucleotide duplex d(5'-GCATGC)2.
    Searle MS; Hall JG; Denny WA; Wakelin LP
    Biochemistry; 1988 Jun; 27(12):4340-9. PubMed ID: 3166981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and dynamics of the antitumor drugs nogalamycin and disnogalamycin complexed to d(CGTACG)2: comparison of crystal and solution structures.
    Robinson H; Yang D; Wang AH
    Gene; 1994 Nov; 149(1):179-88. PubMed ID: 7958983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The intercalation of DNA double helices with doxorubicin and nogalamycin.
    Box VG
    J Mol Graph Model; 2007 Jul; 26(1):14-9. PubMed ID: 17046298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting DNA sequence selectivity of nogalamycin intercalation: the crystal structure of d(TGTACA)2-nogalamycin2.
    Smith CK; Brannigan JA; Moore MH
    J Mol Biol; 1996 Oct; 263(2):237-58. PubMed ID: 8913304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural consequences of a carcinogenic alkylation lesion on DNA: effect of O6-ethylguanine on the molecular structure of the d(CGC[e6G]AATTCGCG)-netropsin complex.
    Sriram M; van der Marel GA; Roelen HL; van Boom JH; Wang AH
    Biochemistry; 1992 Dec; 31(47):11823-34. PubMed ID: 1332773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution conformation of the (-)-cis-anti-benzo[a]pyrenyl-dG adduct opposite dC in a DNA duplex: intercalation of the covalently attached BP ring into the helix with base displacement of the modified deoxyguanosine into the major groove.
    Cosman M; Hingerty BE; Luneva N; Amin S; Geacintov NE; Broyde S; Patel DJ
    Biochemistry; 1996 Jul; 35(30):9850-63. PubMed ID: 8703959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure, dynamics and hydration of the nogalamycin-d(ATGCAT)2Complex determined by NMR and molecular dynamics simulations in solution.
    Williams HE; Searle MS
    J Mol Biol; 1999 Jul; 290(3):699-716. PubMed ID: 10395824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.